Singota Solutions has opened a new facility in Balerna, Switzerland, offering a location touching extensive European ...

On November 28, Changzhou Qianhong Bio-pharma Co., Ltd. started construction of the phase two of pharmaceuticals production facility at Changzhou National Hi-Tech District (CND). With an investment of ...

BridgeBio Pharma plans to offer $500 million in convertible ... reducing interest expenses and enhancing operational flexibility. Additionally, up to $50 million of the net proceeds may be ...

LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing facility ...

BridgeBio Pharma ... the term debt facility significantly lowers interest expenses and eliminates near-term amortization payments, enhancing the company's financial flexibility.